Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open house model for the active ingredient etanercept (ATC code according to WHO: L04AB01
Deadline - Mar 31, 2025
GT reference number - 11296889
Product classification - Medical solutions
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 11296889
Document Type - Tender Notices
Description - Contract notice: conclusion of non-exclusive drug discount agreements according to § 130a para. 8 sgb v by way of a so-called open-house model for the active ingredient etanercept (atc code according to who: l04ab01)The subject of this publication i s the conclusion of non-exclusive discount agreements according to § 130a para. 8 sgb v on drugs with the active ingredient etanercept (atc code according to who: l04ab01). the contract is concluded as part of a so-called open-house model, i. h. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. as a result, individual contract negotiations
Gt Ref Id - 11296889
Deadline - Mar 31, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database